The use of naltrexone in pregnancy in opiate-dependent mothers

Sadie Geraghty, Carly Dixon

Research output: Contribution to journalArticlepeer-review


There is an absence of sufficient evidence regarding naltrexone use in pregnancy due to the limited range of human studies. Naltrexone implants are being used in Western Australia as a treatment for opioid dependency, and although contraindicated for insertion during pregnancy, there are a number of women who conceive while undergoing treatment. A review of the available data revealed that naltrexone is associated with improved maternal and fetal outcomes. Extensive research into this area in the form of large, multicentre trials is required to confirm the results of the current research.

Original languageEnglish
Pages (from-to)503-506
Number of pages4
JournalBritish Journal of Midwifery
Issue number7
Publication statusPublished - Jul 2012
Externally publishedYes


Dive into the research topics of 'The use of naltrexone in pregnancy in opiate-dependent mothers'. Together they form a unique fingerprint.

Cite this